Company Iulius Pharma Srl with Fiscal Code 37024556
recorded a turnover of 2024 of
540.143,
with a net profit of
93.010
and having an average number of employees of
1.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Iulius Pharma Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
-
0
9.122
18.890
75.032
220.917
312.848
388.480
540.143
Total Income - EUR
-
-
0
9.165
22.487
75.101
220.995
313.483
388.705
540.461
Total Expenses - EUR
-
-
1.272
12.854
22.078
62.952
170.272
206.577
292.444
431.144
Gross Profit/Loss - EUR
-
-
-1.272
-3.689
408
12.149
50.723
106.906
96.261
109.317
Net Profit/Loss - EUR
-
-
-1.272
-3.781
184
11.474
48.558
104.004
92.528
93.010
Employees
-
-
0
1
1
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 39.8%, from 388.480 euro in the year 2023, to 540.143 euro in 2024.
The Net Profit increased by 999 euro, from 92.528 euro in 2023, to 93.010 in the last year.
Check the financial reports for the company - Iulius Pharma Srl
Financial Rating - IULIUS PHARMA SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Iulius Pharma Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Iulius Pharma Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Iulius Pharma Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Iulius Pharma Srl - CUI 37024556
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
-
-
112
3.612
12
12
0
0
4.247
62.724
Current Assets
-
-
628
13.013
7.109
20.095
52.686
122.754
132.259
232.361
Inventories
-
-
0
6.411
1.616
8.690
5.105
52.447
67.903
110.323
Receivables
-
-
107
2.551
3.179
4.916
24.825
55.297
26.773
18.667
Cash
-
-
520
4.051
2.314
6.489
22.757
15.009
37.582
103.370
Shareholders Funds
-
-
-1.053
-4.814
-4.537
7.023
46.063
104.531
124.711
93.533
Social Capital
-
-
219
215
211
207
202
203
202
201
Debts
-
-
1.792
21.513
11.658
13.185
6.730
18.222
11.997
202.692
Income in Advance
-
-
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
232.361 euro in 2024 which includes Inventories of
110.323 euro, Receivables of
18.667 euro and cash availability of
103.370 euro.
The company's Equity was valued at
93.533 euro, while total Liabilities amounted to
202.692 euro.
Equity decreased by -30.481 euro, from 124.711 euro in 2023, to 93.533 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Iulius Pharma Srl